key: cord-0807675-hditdtiy
authors: Ludvigsson, Johnny
title: Effect of COVID‐19 pandemic on treatment of Type 1 diabetes in children
date: 2020-10-29
journal: Acta Paediatr
DOI: 10.1111/apa.15627
sha: 1378f5e700d66a31d6d2c97b8b0e36f7329e413a
doc_id: 807675
cord_uid: hditdtiy

Children tend to get very mild symptoms of COVID19 and rarely get severely ill (1), and COVID19 has no specific influence on diabetes other than any other infection (2). However, Covid19 may delay diagnosis, and lock-down of society can lead to that patients with diabetes do not get ordinary care causing poor metabolic control with increasing risks for complications (3,4) and excess mortality (5).

Children tend to get very mild symptoms of COVID19 and rarely get severely ill, 1 and COVID19 has no specific influence on diabetes other than any other infection. 2 However, Covid19 may delay diagnosis, and lock-down of society can lead to that patients with diabetes do not get ordinary care causing poor metabolic control with increasing risks for complications 3, 4 and excess mortality. 5 Sweden has, as the only country, chosen a policy with recommended isolation of the most vulnerable populations, but otherwise a rather open society. As in most countries, the pressure on hospitals and health care has been hard. Ordinary visits to the diabetes team have sometimes been replaced by telemedicine. 6 The aim of this study was to estimate the effects of the covid19 pandemic on treatment of T1D in children.

All patient visits in Sweden are registered in a national data base, SWEDIABKIDS with information about eg HbA1c, blood lipids, use of insulin pumps, glucose sensors. Nationwide information on about 7000 children <18 years of age is available. Data for the periods Jan-July 2018, 2019 and 2020, available through the so called 'Knappen', have been compared, and are presented with 95% confidence intervals.

The results are shown in Table 1 There is a risk that treatment of serious diseases like Type 1 diabetes in children and adolescents deteriorate, which may take long time to repair. With poor metabolic control, we know that there is a increasing risk of vascular complications, and HbA1c has to be kept quite low to avoid long-term complications. 3, 4 Sweden has a tradition of very active treatment of T1D with low mean HbA1c on a national level compared to many other contries. 10 Still those who have got the diagnosis T1D in childhood have a much shorter expected length of life than a reference population. 5 It is therefore extremely important to preserve high quality of care also during the corona pandemic to avoid start of vicious circles.

When physical distancing is necessary to decrease the epidemic, it is natural that visits to hospitals become limited. Then telemedicine is an alternative to ordinary visits to the diabetes team. 6 The effects in the long run are difficult to foresee, but so far during the first 7 months of the epidemic Jan-July 2020, the change of care of children with diabetes and adolescents in Sweden has not impaired treatment.

Modern technical devices such as insulin pumps and glucose sensors are common, and the use has not decreased, but rather the opposite.

Discussions via telephone or internet, for example, Skype and information on glucose profiles and insulin pumps possible to see using Diasend, have probably stimulated some patients and parents to use this information even more actively, as they have been forced to open Diasend at home and not just passively see the blood glucose profiles at hospital visits. So far HbA1c has not increased but remained comparatively low with about 2/3 of the patients with HbA1c < 57 mmol/L (=6.5%) and only ca 6% of the patients with HbA1c > 70 mmol/L, a level which seems to be rather common in several other countries. 10 To use telemedicine as the only alternative will probably not be good enough in the long run, especially not for patients with psychological problems and less stable family situation. Psychological support is crucial and cannot be given with the same quality only per distance. But the situation created by the corona pandemic may give valuable experience, which in the future might improve care when telemedicine is used as a complement. However, we need to be aware of the risk that both diabetes teams and patients/parents continue with telemedicine instead of physical visits, as it seems

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. © 2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica

Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults

COVID-19 in people with diabetes: understanding the reasons for worse outcomes

Arnqvist HJ Impact of HbA1c, followed from onset of type 1 diabetes, on the development of severe retinopathy and nephropathy: the VISS Study (Vascular Diabetic Complications in Southeast Sweden)

HbA 1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study

Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study

Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities

The public health effect of economic crises and alternative policy responses in Europe: an empirical analysis

Economic downturns, universal health coverage, and cancer mortality in high-income and middle-income countries, 1990-2010: a longitudinal analysis

How many infants likely died in Africa as a result of the 2008-2009 global financial crisis?

Exploring variation in glycemic control across and within eight high-income countries: A cross-sectional analysis of 64,666 children and adolescents with Type 1 diabetes

How to cite this article: Ludvigsson J. Effect of COVID-19 pandemic on treatment of Type 1 diabetes in children

TA B L E 1 The table shows the mean percentage (and 95% confidence intervals) of patients with different degree of HbA1c, with low Cholesterol and LDL, and proportion of patients using insulin pumps and glucose sensors during the periods 1 jan-31July 2018 resp 2019 resp 2020